BIT Capital’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-26,237
| Closed | -$1.52M | – | 113 |
|
|
2024
Q3 | $1.52M | Buy |
26,237
+3,499
| +15% | +$203K | 0.14% | 52 |
|
|
2024
Q2 | $1.04M | Buy |
22,738
+10,795
| +90% | +$493K | 0.08% | 66 |
|
|
2024
Q1 | $791K | Buy |
11,943
+1,512
| +14% | +$100K | 0.06% | 84 |
|
|
2023
Q4 | $415K | Buy |
10,431
+3,469
| +50% | +$138K | 0.04% | 56 |
|
|
2023
Q3 | $222K | Hold |
6,962
| – | – | 0.03% | 75 |
|
|
2023
Q2 | $280K | Buy |
+6,962
| New | +$280K | 0.03% | 88 |
|
|
2023
Q1 | – | Sell |
-1,330
| Closed | -$63.9K | – | 142 |
|
|
2022
Q4 | $63.9K | Buy |
+1,330
| New | +$63.9K | 0.01% | 113 |
|
|
2022
Q2 | – | Sell |
-1,700
| Closed | -$92.4K | – | 136 |
|
|
2022
Q1 | $92.4K | Buy |
+1,700
| New | +$92.4K | 0.01% | 98 |
|